Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 11161 - 11168 of 12011 results
California Supreme Court Gives California’s Unfair Competition Law More Coverage
February 11, 2013| Alert| Viewpoint
The Affordable Care Act’s Employer Mandate and the Collectively Bargained Workforce
February 7, 2013| Advisory| Viewpoint
Obama Administration Outlines Religious Accommodations for Contraception Coverage Mandate
February 7, 2013| Blog| Viewpoint
CMS Publishes Proposed Changes to CLIA’s Proficiency Testing Regulations
February 5, 2013| Blog| Viewpoint
ML Strategies Publishes Weekly Health Care Reform Update on February 4, 2013
February 5, 2013| Blog| Viewpoint
CMS Publishes Final Sunshine Act Rule; Data Collection to Begin on August 1, 2013
February 4, 2013| Alert| Viewpoint
New Children’s Product Testing and Certification Rule Set to Impact Manufacturers and Importers on February 8
February 4, 2013| Alert| Viewpoint
Let the Collection and Reporting Begin: CMS Publishes Final Sunshine Act Regulations
February 4, 2013| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|